Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GS-6615 in Chronic Stable Angina and CAD
NCT02377336Phase 2Withdrawn
- Sponsor
- Gilead Sciences
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of eleclazine in angina pectoris, sponsored by Gilead Sciences. Planned start May 2015; status: withdrawn.
02
Drugs
eleclazine
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT02377336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02377336.